Cardio-respiratory arrest, Choking, Aspiration
Drugs: CARBIDOPA\LEVODOPA
- Safetyreportversion
- 1
- Safetyreportid
- 27325193
- Primarysourcecountry
- EU
- Occurcountry
- EU
- Transmissiondateformat
- 102
- Transmissiondate
- 20261010
- Reporttype
- 2
- Serious
- 1
- Seriousnessdeath
- 1
- Seriousnesslifethreatening
- 2
- Seriousnesshospitalization
- 2
- Seriousnessdisabling
- 2
- Seriousnesscongenitalanomali
- 2
- Seriousnessother
- 2
- Receivedateformat
- 102
- Receivedate
- 20260930
- Receiptdateformat
- 102
- Receiptdate
- 20260930
- Fulfillexpeditecriteria
- 1
- Companynumb
- EU-ABBVIE-6956196
- Primarysource
- Reportercountry
- EU
- Qualification
- 5
- Sender
- Sendertype
- 6
- Senderorganization
- ABBVIE
- Receiver
- Receivertype
- 6
- Receiverorganization
- FDA
- Patient
- Patientonsetage
- 72
- Patientonsetageunit
- 801
- Patientsex
- 1
- Reaction
- Reactionmeddraversionpt
- 29.0
- Reactionmeddrapt
- Cardio-respiratory arrest
- Reactionoutcome
- 5
- Reactionmeddraversionpt
- 29.0
- Reactionmeddrapt
- Choking
- Reactionoutcome
- 5
- Reactionmeddraversionpt
- 29.0
- Reactionmeddrapt
- Aspiration
- Reactionoutcome
- 5
- Drug
- Drugcharacterization
- 1
- Medicinalproduct
- CARBIDOPA\LEVODOPA
- Drugbatchnumb
- Not available
- Drugauthorizationnumb
- 203952
- Drugseparatedosagenumb
- 1
- Drugindication
- Parkinson^s disease
- Drugstartdateformat
- 102
- Drugstartdate
- 20250309
- Drugenddateformat
- 102
- Drugenddate
- 20260928
- Drugtreatmentduration
- 18
- Drugtreatmentdurationunit
- 802
- Actiondrug
- 6
- Drugadditional
- 4
- Activesubstance
- Activesubstancename
- CARBIDOPA\LEVODOPA
- Drugcharacterization
- 1
- Medicinalproduct
- CARBIDOPA\LEVODOPA
- Drugauthorizationnumb
- 203952
- Actiondrug
- 6
- Drugadditional
- 4
- Activesubstance
- Activesubstancename
- CARBIDOPA\LEVODOPA
- Summary
- Narrativeincludeclinical
- CASE EVENT DATE: 20260928
